Journal of the American Heart Association

JANUARY 12, 2024

ABSTRACT: Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease. Albuminuria is associated with an increased risk of coronary artery disease, stroke, heart failure, arrhythmias, and microvascular disease.

Cardiovascular Disease 71

Cardiovascular Disease Risk Factors Coronary Artery Disease Kidney Disease 71

GEMMS

MAY 22, 2024

Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g., Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

By comparing myocardial injury patients with non-myocardial injury patients, notable differences were observed in age, pre-existing medical conditions (e.g.,

Risk Factors 64

Risk Factors Laboratory Coronary Artery Disease Cerebrovascular Disease 64

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. ILRs detected various arrhythmias, with ventricular arrhythmias linked to spontaneous type 1 ECGs and fever. New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59